Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).
暂无分享,去创建一个
Clive R. Taylor | J. Taube | C. Horak | Xiaoling Zhang | A. Gupta | J. Cogswell | G. Kollia | R. Anders | M. Jure-Kunkel | J. Grosso | J. Simon | J. Novotny | D. Cardona | Diana M. Cardona | Jong-Soon Park | T. Phillips | David Inzunza | V. Sankar | P. Simmons | C. Taylor | Therese Phillips | Jong‐Soon Park